INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X951. A total of 3 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,802,314 | +64.5% | 34,600 | +100.0% | 0.01% | +50.0% |
| Q2 2023 | $1,095,436 | -43.0% | 17,300 | -52.3% | 0.00% | 0.0% |
| Q4 2022 | $1,920,996 | +7.5% | 36,300 | -5.5% | 0.00% | 0.0% |
| Q3 2022 | $1,787,000 | +32.7% | 38,400 | +62.7% | 0.00% | +100.0% |
| Q2 2022 | $1,347,000 | +72.0% | 23,600 | +84.4% | 0.00% | +100.0% |
| Q1 2022 | $783,000 | -30.1% | 12,800 | -40.2% | 0.00% | 0.0% |
| Q4 2021 | $1,120,000 | +24.2% | 21,400 | -11.6% | 0.00% | 0.0% |
| Q3 2021 | $902,000 | +4.8% | 24,200 | +14.7% | 0.00% | 0.0% |
| Q2 2021 | $861,000 | +13.3% | 21,100 | -5.8% | 0.00% | 0.0% |
| Q1 2021 | $760,000 | -58.1% | 22,400 | -60.7% | 0.00% | -66.7% |
| Q4 2020 | $1,813,000 | -60.6% | 57,000 | -68.2% | 0.00% | -78.6% |
| Q3 2020 | $4,598,000 | +36.7% | 179,200 | +36.8% | 0.01% | -12.5% |
| Q2 2020 | $3,363,000 | +560.7% | 131,000 | +295.8% | 0.02% | +300.0% |
| Q1 2020 | $509,000 | -98.8% | 33,100 | -97.3% | 0.00% | -98.6% |
| Q4 2019 | $41,357,000 | +821.9% | 1,205,400 | +100.7% | 0.28% | +680.6% |
| Q3 2019 | $4,486,000 | +175.6% | 600,500 | +378.9% | 0.04% | +140.0% |
| Q2 2019 | $1,628,000 | +2329.9% | 125,400 | +2180.0% | 0.02% | +1400.0% |
| Q1 2019 | $67,000 | -95.4% | 5,500 | -95.7% | 0.00% | -92.3% |
| Q4 2018 | $1,451,000 | -38.9% | 127,400 | +16.3% | 0.01% | -31.6% |
| Q3 2018 | $2,376,000 | -49.2% | 109,500 | -58.6% | 0.02% | -52.5% |
| Q2 2018 | $4,675,000 | -13.7% | 264,600 | +2.8% | 0.04% | -27.3% |
| Q1 2018 | $5,416,000 | +120.8% | 257,300 | +51.9% | 0.06% | +223.5% |
| Q4 2017 | $2,453,000 | -7.6% | 169,400 | +0.7% | 0.02% | -29.2% |
| Q3 2017 | $2,654,000 | +334.4% | 168,200 | +241.9% | 0.02% | +300.0% |
| Q2 2017 | $611,000 | +10.3% | 49,200 | +44.3% | 0.01% | 0.0% |
| Q1 2017 | $554,000 | +10980.0% | 34,100 | +11266.7% | 0.01% | – |
| Q4 2016 | $5,000 | -98.3% | 300 | -98.4% | 0.00% | -100.0% |
| Q3 2016 | $293,000 | -78.8% | 19,200 | -46.1% | 0.00% | -81.2% |
| Q2 2016 | $1,382,000 | +35.1% | 35,600 | -3.3% | 0.02% | +14.3% |
| Q1 2016 | $1,023,000 | -45.5% | 36,800 | +5.4% | 0.01% | -36.4% |
| Q4 2015 | $1,877,000 | -7.0% | 34,900 | -30.8% | 0.02% | -21.4% |
| Q3 2015 | $2,018,000 | +2331.3% | 50,400 | +1838.5% | 0.03% | +2700.0% |
| Q2 2015 | $83,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 34,600 | $1,802,314 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 8,300 | $432 | 0.00% |